Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOX4 | Q9NPH5 | 1/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | GALR3 | O60755 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | DPP4 | P27487 | 2/20 | 0.40 |
| ▸ | GRIN1 | Q05586 | 3/20 | 0.40 |
| ▸ | GRIN2B | Q13224 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 3/20 | 0.37 |
| ▸ | TNKS | O95271 | 1/20 | 0.37 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6895661 | 0.91 | NOX4 (0.39) | NOX4RXFP1ALDH1A1TSHRGALR3 | |
| SCHEMBL6775552 | 0.90 | TSHR (0.43) | NOX4RXFP1ALDH1A1TSHRGALR3 | |
| SCHEMBL6891000 | 0.89 | GRIN1 (0.43) | NOX4RXFP1ALDH1A1TSHRGALR3 | |
| SCHEMBL6692711 | 0.89 | ALDH1A1 (0.46) | NOX4RXFP1ALDH1A1TSHRGALR3 | |
| SCHEMBL6896480 | 0.89 | GRIN1 (0.45) | NOX4RXFP1ALDH1A1TSHRGALR3 | |
| SCHEMBL6891308 | 0.87 | TSHR (0.42) | NOX4RXFP1ALDH1A1TSHRGALR3 | |
| SCHEMBL6894723 | 0.86 | MAPT (0.45) | ALDH1A1TSHRKDM4EHPGDHSD17B10 | |
| SCHEMBL6895819 | 0.85 | GRIN1 (0.50) | NOX4RXFP1ALDH1A1TSHRGALR3 | |
| SCHEMBL6892130 | 0.85 | HSP90AA1 (0.38) | NOX4ALDH1A1TSHRRAB9AKDM4E | |
| SCHEMBL6892764 | 0.85 | LMNA (0.44) | RXFP1ALDH1A1TSHRKDM4ESMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6713645-B1 | INHIBITING SPLA2 MEDIATED RELEASE OF FATTY ACIDS FOR TREATMENT OF CONDITIONS SUCH AS SEPTIC SHOCK | ELI LILLY AND COMPANY | 2004-03-30 | — | — | US | disclosed |
| US-6177440-B1 | THERAPY FOR SEPSIS SHOCK; PHOSPHOLIPASE INHBITOR | ELI LILLY AND COMPANY | 2001-01-23 | — | — | US | disclosed |
| EP-0952149-A2 | Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors | ELI LILLY AND COMPANY (US) | 1999-10-27 | — | — | EP | disclosed |